ROCCHICCIOLI, SILVIA
 Distribuzione geografica
Continente #
AS - Asia 2.562
NA - Nord America 1.951
EU - Europa 867
SA - Sud America 389
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 40
OC - Oceania 4
Totale 6.028
Nazione #
US - Stati Uniti d'America 1.840
SG - Singapore 1.060
CN - Cina 542
IT - Italia 325
BR - Brasile 316
HK - Hong Kong 300
VN - Vietnam 255
FR - Francia 137
NL - Olanda 105
JP - Giappone 77
KR - Corea 75
BD - Bangladesh 72
FI - Finlandia 64
DE - Germania 56
IN - India 52
GB - Regno Unito 49
CA - Canada 40
AR - Argentina 31
MX - Messico 23
TR - Turchia 19
ES - Italia 18
IQ - Iraq 17
AT - Austria 16
JM - Giamaica 16
ID - Indonesia 14
PL - Polonia 13
SE - Svezia 13
IL - Israele 12
UZ - Uzbekistan 12
RU - Federazione Russa 11
CR - Costa Rica 10
IR - Iran 10
MA - Marocco 10
CO - Colombia 9
IE - Irlanda 9
ZA - Sudafrica 9
CL - Cile 7
VE - Venezuela 7
AZ - Azerbaigian 6
EC - Ecuador 6
GR - Grecia 6
PK - Pakistan 6
SA - Arabia Saudita 6
TN - Tunisia 6
AL - Albania 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KZ - Kazakistan 5
LT - Lituania 5
PH - Filippine 5
TT - Trinidad e Tobago 5
UA - Ucraina 5
AU - Australia 4
EE - Estonia 4
KE - Kenya 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
NI - Nicaragua 3
PE - Perù 3
PY - Paraguay 3
BE - Belgio 2
CH - Svizzera 2
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
LB - Libano 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MV - Maldive 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
Totale 5.812
Città #
Singapore 621
Santa Clara 403
Hong Kong 295
San Jose 236
Ashburn 194
Hefei 181
Beijing 153
Los Angeles 138
Dallas 125
Lauterbourg 109
Ho Chi Minh City 97
Seoul 72
Tokyo 62
Hanoi 54
New York 47
Pisa 38
São Paulo 27
Milan 26
Modena 26
Buffalo 23
Helsinki 23
Lappeenranta 23
Cascina 22
Orem 22
Turku 18
Frankfurt am Main 16
Phoenix 16
Montreal 15
Atlanta 14
Florence 14
Rio de Janeiro 14
Haiphong 13
London 13
Denver 11
Livorno 11
Munich 11
Naples 11
Stockholm 11
Tashkent 11
Belo Horizonte 10
Biên Hòa 10
Council Bluffs 10
Nuremberg 10
Warsaw 10
Bengaluru 9
Bologna 9
Brooklyn 9
Chennai 9
Kingston 9
Minamishinagawa 9
Mumbai 9
Boston 8
Chicago 8
Dublin 8
Istanbul 8
Manchester 8
Rome 8
Brasília 7
Charlotte 7
Dhaka 7
Düsseldorf 7
Johannesburg 7
Mexico City 7
Newark 7
San Francisco 7
Ankara 6
Da Nang 6
Houston 6
Hyderabad 6
Indianapolis 6
Porto Alegre 6
Vienna 6
Amsterdam 5
Athens 5
Baghdad 5
Casablanca 5
Casalmaggiore 5
City of London 5
Curitiba 5
Hải Dương 5
Jena 5
Madrid 5
Palermo 5
Paris 5
Poplar 5
Shanghai 5
Toronto 5
Baku 4
Catania 4
Columbus 4
Detroit 4
Manaus 4
Osasco 4
Philadelphia 4
Piscataway 4
Quận Một 4
Turin 4
Acalanes Ridge 3
Alajuela 3
Araruama 3
Totale 3.599
Nome #
SMARTool: Interim Progress Report (M19-M30) 131
SMARTool - Periodic Technical Report - PART B (Period 2) 116
Health improvements by Understanding Residual Risk In CAd and NEw targets for prevention/treatment: Rationale and Research Protocol of the HURRICANE project 116
The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis 114
Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial 99
Dem-Aging: autophagy-related pathologies and the “two faces of dementia” 98
Homotypic targeting and drug delivery in glioblastoma cells through cell membrane-coated boron nitride nanotubes 96
Discrimination capability of pretest probability of stable coronary artery disease: a systematic review and meta-analysis suggesting how to improve validation procedures 95
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial 94
Validated models for pre-test probability of stable coronary artery disease: a systematic review suggesting how to improve validation procedures 88
Association of circulating neutrophils with relative volume of lipid-rich necrotic core of coronary plaques in stable patients: a substudy of SMARTool european project 87
Proteomic Modulation in TGF-b-Treated Cholangiocytes Induced by Curcumin Nanoparticles 82
Effect of Neutrophil–Platelet Interactions on Cytokine-Modulated Expression of Neutrophil CD11b/CD18 (Mac-1) Integrin Complex and CCR5 Chemokine Receptor in Stable Coronary Artery Disease: A Sub-Study of SMARTool H2020 European Project 78
Blood M2-like Monocyte Polarization Is Associated with Calcific Plaque Phenotype in Stable Coronary Artery Disease: A Sub-Study of SMARTool Clinical Trial 78
Saliva Proteome of Primary Sclerosing Cholangitis: A Pilot Study to demonstrate its clinical utility 77
A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome 77
Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model 74
Predictive added value of selected plasma lipids to a re-estimated minimal risk tool 74
Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease 73
Lysosomal Proteomics Links Disturbances in Lipid Homeostasis and Sphingolipid Metabolism to CLN5 Disease 72
Medium-term effect of sublingual L-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors 69
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina 68
Lipidomic analysis to assess the correlation between ceramides, stress hyperglycemia, and HbA1c in acute myocardial infarction 67
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS) 66
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 65
INSILC D9.2. - HCT - Requirement No. 2 64
Protein Delivery by Peptide-Based Stealth Liposomes: A Biomolecular Insight into Enzyme Replacement Therapy 63
Maternal Obesity and Cardiac Development in the Offspring Study in Human Neonates and Minipigs 63
Chiral N-Allylpyrroles as Versatile Substrates Under Rhodium Catalyzed Hydroformylation: Good Regio- and Diastereo Selectivity at Room Temperature and High Pressure 62
A different trend of heat shock proteins 90 mRNA and protein in hepatocellular carcinoma cell line-secreted extracellular vesicles. 62
A targeted LC-MS/MS analysis of circulatory lipid profile to highlight biomarkers for patient stratification according to coronary artery disease severity 62
Rhodium catalyzed hydroformylation of beta-isophorone: an unexpected result 59
Tangier disease: a plasma proteome approach 59
Molecular characterization of plasma HDL, LDL, and VLDL lipids cargos from atherosclerotic patients with advanced carotid lesions: a preliminary report 58
Transcriptional level evaluation of osteopontin/miRNA-181a axis in hepatocellular carcinoma cell line-secreted extracellular vesicles 57
Biological effects of Transforming Growth Factor Beta in human cholangiocytes 57
Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients 56
Salivary proteomics markers for preclinical Sjögren's Syndrome: a pilot study 56
SMARTool: Periodic Technical Report - Part B 56
Impact of Clinical Characteristics and Statins on Coronary Plaque Progression by Serial Computed Tomography Angiography 55
Proof of concept of a new plasma complement Factor H from waste plasma fraction 55
Brain histone beta-hydroxybutyrylation couples metabolism with gene expression 55
Integrative human and murine multi-omics: Highlighting shared biomarkers in the neuronal ceroid lipofuscinoses 55
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 55
Biohumoral predictors of coronary atherosclerosis progression in patients with suspected coronary artery disease from the SMARTool Study 54
Relazione 3 (finale): Relazione finale protocollata e stesura di un protocollo analitico definitivo con gli step raggiunti su metodo per analisi quantitativa HPLC-QTRAP 54
Lipid biomarkers in statin users with coronary artery disease annotated by coronary computed tomography angiography 54
A gel-free approach in vascular smooth muscle cell proteome: perpectives for a better insight into activation 54
Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. 52
A targeted LC-MS/MS analysis of the human plasma lipid profile to highlight novel markers of coronary artery disease severity 52
SMARTool - Interim Report M19-M24 51
Comparative proteomics profiling through DIA-SWATH-MS analysis in WT vs PPT1 KO "neuron-like" human cell lines as CLN1 model 51
Cardiac troponins: Mechanisms of release and role in healthy and diseased subjects 50
Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach. 48
Proteomics pipeline for phosphoenrichment and its application on a human melanoma cell model 48
Biological and Proteomic characterization of a composite mesh for abdominal wall hernia treatment: Reference Study 47
Proteomic analyses and integrative omics approach to highlight the common molecular signatures for different NCL forms 47
Characterization of secreted vesicles from vascular smooth muscle cells 45
Apolipoprotein E ?4 triggers neurotoxicity via cholesterol accumulation, acetylcholine dyshomeostasis, and PKC? mislocalization in cholinergic neuronal cells 45
CMC composite mesh: biological characterization, proteomic analysis and anisotropy as reference study for "MES-STAR" Manunet II - European research project 45
Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization 45
Metodo per la separazione dei costituenti di miscele complesse di proteine da sottoporre ad analisi proteomica e apparecchiatura che attua tale metodo 45
Proteomics changes in adhesion molecules: a driving force for vascular smooth muscle cell phenotypic switch 44
A common plasma lipidomics signature of cardiometabolic and coronary risk in statin users 44
The landscape of BRAF transcript and protein variants in human cancer 44
Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression 43
Modulated molecular markers of restenosis and thrombosis by in-vitro vascular cells exposed to bioresorbable scaffolds 43
Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin 43
Secretome modulation by high-cholesterol diet in pig coronary arteries 43
HDL-Mediated Protection of Coronary Vasodilator Response to Adenosine in the Hypercholesterolemic Swine. 42
Quantitative CTA analysis of coronary plaque progression in SMARTool clinical study: the association between baseline clinical parameters and plaque progression 42
Coronary vascular smooth muscle cell proteins in the hypercholesterolemic swine: plaque-related markers of accelerated atherogenesis 41
Site-specific secretome map evidences VSMC-related markers of coronary atherosclerosis grade and extent in the hypercholesterolemic swine 41
Characterization of Extracellular Vesicle Cargo in Sjogren's Syndrome through a SWATH-MS Proteomics Approach 40
RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells 40
Integration of Biomechanical and Biological Characterization in the Development of Porous Poly(caprolactone)-Based Membranes for Abdominal Wall Hernia Treatment 40
FOCUS ON RELEASED EXTRACELLULAR MATRIX COMPONENTS FROM CAROTID PLAQUE CORE: INTACT PROTEINS OR FRAGMENTS? 39
Proteomics Techniques for the Detection of Translated Pseudogenes 39
An automated plasma protein fractionation design: High-throughput perspectives for proteomic analysis 36
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes. 36
CMC COMPOSITE MESH: BIOLOGICAL CHARACTERIZATION, PROTEOMIC ANALYSIS AND ANISOTROPY AS REFERENCE STUDY FOR "MES­STAR" MANUNET II ­ EUROPEAN RESEARCH PROJECT 36
Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach 36
From chiral and prochiral N-allylpyrroles to stereodefined pyrrole fused architectures: a particular application of the rhodium catalyzed hydroformylation 36
CMC COMPOSITE MESH: BIOCHEMICAL AND BIOMECHANICAL ANALYSIS 36
Non-Invasive Prediction of Site-Specific Coronary Atherosclerotic Plaque Progression using Lipidomics, Blood Flow, and LDL Transport Modeling 35
Quantitative CTA Analysis of Coronary Plaque Progression in SMARTool Clinical Study: The Association Between Baseline Clinical Parameters and Plaque Progression 35
Synthesis of 5,6,7,8-tetrahydroindolizines via a domino-Type transformation based on the rhodium catalyzed hydroformylation of N-(â-methallyl)pyrroles 35
Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease 35
Vascular smooth muscle cell proteome changes in a high fat diet animal model of atherogenesis 34
SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data 33
Complete 1,3-asymmetric induction into 3-methyl-(3-acetylpyrrol-1-yl)butanal to 1-acetyl-6-methyl-8-hydroxy-5,6,7,8-tetrahydroindolizine cyclization 33
Computational prediction of the regio- and diastereoselectivity in a rhodium-catalyzed hydroformylation/cyclization domino process 32
Machine Learning Coronary Artery Disease Prediction Based on Imaging and Non-Imaging Data 31
A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation 30
Sex differences in coronary plaque changes assessed by serial computed tomography angiography 30
Proteomics and personalized medicine 30
[18F]insulin for PET imaging applications: simple and chemoselective two step reaction based on combined microfluidic-vessel chemistry 30
Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells. 29
Method for separating the constituents of a complex mixture of proteins to submit to proteomic analysis and apparatus therefor 28
VASCULAR SMOOTH-MUSCLE-CELL ACTIVATION: PROTEOMICS POINT OF VIEW 28
Totale 5.542
Categoria #
all - tutte 20.331
article - articoli 16.086
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 258
Totale 36.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202499 0 0 0 0 0 0 0 0 10 65 23 1
2024/20252.125 56 16 164 68 411 78 69 152 120 149 486 356
2025/20263.585 183 276 339 508 671 165 552 107 188 280 177 139
2026/2027219 215 4 0 0 0 0 0 0 0 0 0 0
Totale 6.028